3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroblastoma
1
Meningioma
1
Medulloblastoma
1
Interventions
Magnetic Resonance Spectroscopy
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
thymoglobulin
1
gallium Ga 68 dotatate
1
fludarabine phosphate
1
arginyllysine
1
Whole Body Imaging
1
Valproic Acid
1
Thiotepa
1
Temozolomide
1
Tacrolimus
1
Stem Cell Transplantation
1
Nivolumab
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
LY2940680
1
Hematopoietic Stem Cell Transplantation
1
Gadolinium DTPA
1
Etoposide
1
Erlotinib Hydrochloride
1
Drug Therapy
1
Biopsy
1
Bandages
1
Azacitidine
1
Antilymphocyte Serum
1
Amino Acids
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Medulloblastoma
×
Whole Body Imaging
×
Clear all
NCT03013387
2017-08-25
Dosimetry Guided PRRT With 90Y-DOTATOC
University of Iowa
Phase 2
Withdrawn